Akero Therapeutics Total Current Liabilities 2011-2026 | AKRO

Annual Total Current Liabilities Akero Therapeutics

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
39.8 M	19.1 M	19.1 M	25.1 M	13.1 M	9.37 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
39.8 M	9.37 M	20.9 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Current Liabilities	Price	% 24h	Market Cap	Country
Aeglea BioTherapeutics AGLE	58.7 M	-	-	$ 1.01 B	USA
I-Mab IMAB	576 M	-	-	$ 866 M	China
AIkido Pharma AIKI	1.61 M	-	1.93 %	$ 17.4 M	USA
Alexion Pharmaceuticals, Inc. ALXN	1.62 B	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	4.59 M	$ 0.9	-2.33 %	$ 6.62 M	China
ACADIA Pharmaceuticals ACAD	395 M	$ 21.96	-0.68 %	$ 3.64 B	USA
Allakos ALLK	36.6 M	-	-	$ 28.6 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	1.77 M	-	-1.52 %	$ 24.7 M	USA
Advaxis ADXS	25 M	-	-9.65 %	$ 45.9 M	USA
AlloVir ALVR	9.71 M	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	2.38 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	15.1 M	-	-	$ 10.1 M	USA
Akouos AKUS	16.8 M	-	0.23 %	$ 488 M	USA
Aligos Therapeutics ALGS	21.2 M	$ 6.4	4.4 %	$ 63.3 M	USA
Applied Therapeutics APLT	71.2 M	-	-	$ 8.42 M	USA
Aptinyx APTX	6.29 M	-	-39.0 %	$ 4.57 M	USA
Aridis Pharmaceuticals ARDS	36.9 M	-	17.91 %	$ 11.1 M	USA
Avenue Therapeutics ATXI	1.1 M	-	-52.27 %	$ 4.45 M	USA
Amphastar Pharmaceuticals AMPH	158 M	$ 21.41	1.9 %	$ 1 B	USA
Aravive ARAV	22.1 M	-	-13.39 %	$ 1.45 M	USA
Институт стволовых клеток человека ISKJ	556 M	-	-	-	Russia
BioDelivery Sciences International BDSI	82.4 M	-	-4.8 %	$ 255 M	USA
Brainstorm Cell Therapeutics BCLI	11 M	-	-2.5 %	$ 5.88 M	USA
AgeX Therapeutics AGE	3.56 M	-	-10.17 %	$ 12.2 K	USA
BeiGene, Ltd. BGNE	1.83 B	-	0.49 %	$ 251 B	Cayman-islands
Ayala Pharmaceuticals AYLA	7.54 M	-	-	$ 7.46 M	Israel
Applied Genetic Technologies Corporation AGTC	25.2 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	47.6 M	$ 4.08	0.25 %	$ 436 M	USA
Arcutis Biotherapeutics ARQT	130 M	$ 23.26	1.75 %	$ 2.96 B	USA
Cara Therapeutics CARA	11 M	-	-3.03 %	$ 260 M	USA
Autolus Therapeutics plc AUTL	73.4 M	$ 1.44	-5.88 %	$ 383 M	Britain
Aptose Biosciences APTO	9.31 M	-	-45.71 %	$ 1.2 M	Canada
BioXcel Therapeutics BTAI	53.9 M	$ 1.06	-3.64 %	$ 12.9 M	USA
CASI Pharmaceuticals CASI	13.2 M	-	-	$ 35.4 M	USA
AVROBIO AVRO	6.35 M	-	1083.1 %	$ 745 M	USA
Cabaletta Bio CABA	50.2 M	$ 2.95	-3.28 %	$ 296 M	USA
Can-Fite BioPharma Ltd. CANF	2.73 M	$ 2.91	-1.36 %	$ 4.79 M	Israel
bluebird bio BLUE	200 M	-	-	$ 546 M	USA
CymaBay Therapeutics CBAY	36.8 M	-	-	$ 3.45 B	USA